Cargando…
Identification of Prognostic Markers of Gynecologic Cancers Utilizing Patient-Derived Xenograft Mouse Models
SIMPLE SUMMARY: As a preclinical model for personalized cancer therapy, the patient-derived xenograft (PDX) model is suitable because it provides the best representation of the original tumor, but it still has many limitations. We analyzed gynecologic cancer PDX models with their clinical informatio...
Autores principales: | Shin, Ha-Yeon, Lee, Eun-ju, Yang, Wookyeom, Kim, Hyo Sun, Chung, Dawn, Cho, Hanbyoul, Kim, Jae-Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834149/ https://www.ncbi.nlm.nih.gov/pubmed/35159096 http://dx.doi.org/10.3390/cancers14030829 |
Ejemplares similares
-
Accumulation of cytoplasmic Cdk1 is associated with cancer growth and survival rate in epithelial ovarian cancer
por: Yang, Wookyeom, et al.
Publicado: (2016) -
TOM40 Inhibits Ovarian Cancer Cell Growth by Modulating Mitochondrial Function Including Intracellular ATP and ROS Levels
por: Yang, Wookyeom, et al.
Publicado: (2020) -
Establishment of five immortalized human ovarian surface epithelial cell lines via SV40 T antigen or HPV E6/E7 expression
por: Shin, Ha-Yeon, et al.
Publicado: (2018) -
Comparison of Clinical Features and Outcomes in Epithelial Ovarian Cancer according to Tumorigenicity in Patient-Derived Xenograft Models
por: Eoh, Kyung Jin, et al.
Publicado: (2018) -
Identification of a novel gene signature in second-trimester amniotic fluid for the prediction of preterm birth
por: Kim, Min-A, et al.
Publicado: (2022)